Biotech & MedTech
-
Greg Fenton on how Zentek’s Advancement in Aptamer Technology is Revolutionizing Biotech
In an interview with host Tracy Weslosky from InvestorNews, Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO Greg…
-
Progress in Pathogen Defense, Dr. Carolyn Myers Discusses FendX’s Collaboration with Dunmore for REPELWRAP™
In a recent interview with InvestorNews host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President, CEO,…
-
Greg Fenton on China’s graphite export restrictions and Zentek’s Albany graphite deposit in Ontario
In a recent InvestorNews interview with host Tracy Weslosky, Zentek Ltd.’s (NASDAQ: ZTEK | TSXV: ZEN) CEO and…
-
Exploring the FendX strategic vision for products focused on infectious disease control with Dr. Carolyn Myers
In a recent interview with Investor.News host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President,…
-
InvestorNews Today: Zentek, Australian Strategic Materials and the Global Markets
August 28, 2023 — Enjoying the new name for InvestorIntel, we are in the final countdown for a…
-
FendX Technologies is a germaphobes new best friend
How often do you find yourself with subtle post pandemic habits, like pushing doors open with your elbow…
-
FendX Technologies’ award winning nanotechnology and REPELWRAP™ film is advancing at warp speed
One day in the future there could be special nanomaterials used in hospitals, operating theaters, and medical clinics…
-
With an effective anti-inflammatory and anti-fibrotic agent, Cardiol Therapeutics is focused on our hearts
Trialing cannabidiol-based therapies for pericarditis and myocarditis while developing new therapies for heart failure — Cardiol is well-capitalized…
